Your browser doesn't support javascript.
loading
FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper.
Herzog, Thomas J; Ison, Gwynn; Alvarez, Ronald D; Balasubramaniam, Sanjeeve; Armstrong, Deborah K; Beaver, Julia A; Ellis, Annie; Tang, Shenghui; Ford, Peg; McKee, Amy; Gershenson, David M; Kim, Geoffrey; Monk, Bradley J; Pazdur, Richard; Coleman, Robert L.
Affiliation
  • Herzog TJ; University of Cincinnati Cancer Institute, Dept. of Ob/Gyn, University of Cincinnati, United States.
  • Ison G; Office of Hematology Oncology Products, OND, CDER, FDA, United States.
  • Alvarez RD; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Balasubramaniam S; Office of Hematology Oncology Products, OND, CDER, FDA, United States.
  • Armstrong DK; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States.
  • Beaver JA; Office of Hematology Oncology Products, OND, CDER, FDA, United States.
  • Ellis A; Ovarian Cancer Survivor, White Plains, New York.
  • Tang S; Division of Biometrics V, OB, OTS, CDER, FDA, United States.
  • Ford P; Ovarian Cancer Alliance of San Diego, United States.
  • McKee A; Office of Hematology Oncology Products, OND, CDER, FDA, United States.
  • Gershenson DM; U.S. Oncology, Phoenix, AZ, United States.
  • Kim G; Office of Hematology Oncology Products, OND, CDER, FDA, United States.
  • Monk BJ; U.S. Oncology, Phoenix, AZ, United States.
  • Pazdur R; Oncology Center of Excellence, OMPT, FDA, United States.
  • Coleman RL; Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: rcoleman@mdanderson.org.
Gynecol Oncol ; 147(1): 3-10, 2017 10.
Article in En | MEDLINE | ID: mdl-28844539
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Clinical Trials as Topic / Neoplasms, Glandular and Epithelial / Endpoint Determination Type of study: Clinical_trials Aspects: Patient_preference Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: Gynecol Oncol Year: 2017 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Clinical Trials as Topic / Neoplasms, Glandular and Epithelial / Endpoint Determination Type of study: Clinical_trials Aspects: Patient_preference Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: Gynecol Oncol Year: 2017 Document type: Article Affiliation country: United States